pimobendan has been researched along with catechin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Ando, H; Fukuzawa, Y; Hotta, Y; Huang, L; Ishikawa, N; Miyazeki, K; Muto, T; Nonogaki, T; Tushima, H; Wakida, Y; Yajima, M | 1 |
2 other study(ies) available for pimobendan and catechin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Positive inotropic effect of purified green tea catechin derivative in guinea pig hearts: the measurements of cellular Ca2+ and nitric oxide release.
Topics: Animals; Blood Pressure; Calcium; Cardiotonic Agents; Catechin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Guinea Pigs; Heart; Heart Ventricles; In Vitro Techniques; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Perfusion; Pyridazines; Rabbits; Signal Transduction; Tea; Vasodilator Agents; Ventricular Function; Ventricular Pressure | 2006 |